ArticlePregnancy (Hoboken, N.J.)2025
Prenatal diagnosis mediates the relationship between disease complexity and intervention timing for congenital heart defects.
Article in Pregnancy (Hoboken, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Discharge Barriers and Length of Stay Following Congenital Heart Surgery: A Mixed-Methods Approach.Journal of the American Heart Association · 2026Article
- Enhancing Fetal Cardiac Care: Addressing Unwarranted Variation in Prenatal Congenital Heart Disease Detection and Counseling.Current cardiology reports · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Introduction: Previous studies comparing timing of postnatal intervention among patients with prenatal versus postnatal diagnosis of a congenital heart defect (CHD) have yielded conflicting results due to challenges in controlling for CHD complexity. The objective of this analysis is to take an alternative approach: to determine whether prenatal diagnosis mediates, or explains, the relationship between CHD complexity and age at intervention. Methods: A retrospective cohort study including infants who received intervention for CHD at < 60 days of life, 2015-2021, at a high-volume CHD surgical center. The exposure was CHD complexity (low, moderate, and high). The mediator was prenatal diagnosis (yes, no). The outcome was age at intervention (cardiac surgery or interventional catheterization, whichever came first) in days. Covariates included sociodemographic and clinical characteristics of the pregnant individual and infant. Mediation analysis used linear probability regressions with a COVID-19-era fixed effect and robust standard errors. Results: Of 429 infants, 28% had high-, 63% had moderate-, and 8% had low-complexity CHD; 68% had a prenatal diagnosis. The median age at intervention was 6 (IQR 4-14) days. In adjusted models, prenatal diagnosis mediated 27%-29% of the association between CHD complexity and age at intervention (indirect effects: moderate complexity vs. low complexity: 3.7, 95%CI 1.4-6.1 days; high complexity vs. low complexity: 5.5, 95%CI 2.2-8.8 days). Conclusion: Complex CHDs are intervened upon earlier, partly because they are likelier to be prenatally detected, than low-complexity defects. Prenatal diagnosis plays a mechanistic role in improving access to care for infants with complex CHD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.